Efficacy of bevacizumab by intravitreal route in choroidal neovascular membrane of eye.
Phase 4
- Conditions
- Health Condition 1: null- Patients having Choroidal Neovasuclar membrane
- Registration Number
- CTRI/2016/09/007288
- Lead Sponsor
- Govt medical college and sir takhtsinhji hospital bhavnagr
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
patiets having choroidal neovascular membrane
Exclusion Criteria
Patients who are not giving written and informed consent for participation in the study.
Known patient of diabetic retinopathy, hypertensive retinopathy, macular disorder like macular hole macular haemorrhage macular dystrophies
Pre-Existing pathology in eye eg. Corneal macular or optic nerve disorder, active infection of any structure of eye.
Any Choroidal Pathology.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vision and Intraocular pressure changesTimepoint: <br/ ><br>after 6 hours, 48 hours and 7 days for any early and late complications
- Secondary Outcome Measures
Name Time Method dye leakge in FFATimepoint: after one month of last injection